Menu

Experience

Jennifer Shanley

    • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 


    • General Catalyst Leads Eleanor Health’s $50 Million Series C  


    • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 


    • Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion 


    • Flexion Therapeutics Agrees to Sell to Pacira BioSciences 


    • Warby Parker – Direct Listing 


    • ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million 


    • Lyell Immunopharma – $425 Million IPO 


    • Olive Closes $225 Million Financing, Acquires Verata Health 


    • Opthea – $128 Million IPO 


    • ArcherDX Agrees to Combine With Invitae in $2.7 Billion Deal 


    • Orca Bio Raises $192 Million Series D to Transform Allogenic Cell Therapy 


    • Avidity Biosciences - $289 Million IPO 


    • Vaxcyte - $288 Million IPO 


    • Reata Pharmaceuticals – $505 Million Follow-On Offering 


    • argenx – $557 Million Follow-On Offering